(2011). Bevacizumab: a New Potential Therapeutic Option in Sinusoidal Obstruction Syndrome. Asian Pacific Journal of Cancer Prevention, 12(8), 2147-2148.
MLA
. "Bevacizumab: a New Potential Therapeutic Option in Sinusoidal Obstruction Syndrome". Asian Pacific Journal of Cancer Prevention, 12, 8, 2011, 2147-2148.
HARVARD
(2011). 'Bevacizumab: a New Potential Therapeutic Option in Sinusoidal Obstruction Syndrome', Asian Pacific Journal of Cancer Prevention, 12(8), pp. 2147-2148.
VANCOUVER
Bevacizumab: a New Potential Therapeutic Option in Sinusoidal Obstruction Syndrome. Asian Pacific Journal of Cancer Prevention, 2011; 12(8): 2147-2148.
)